Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Reexamination Certificate
2006-04-25
2009-06-30
Campell, Bruce (Department: 1648)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
C424S085100
Reexamination Certificate
active
07553932
ABSTRACT:
Compositions, methods and uses employing interleukin-10 receptor (IL-10R) or interleukin 10R ligand (e.g., IL-10) antagonists for viral treatment, identification, screening and diagonistics.
REFERENCES:
patent: 6818748 (2004-11-01), Fulton et al.
patent: 2004/0142893 (2004-07-01), Ikeda et al.
patent: 98/10787 (1998-03-01), None
patent: WO 98/10792 (1998-03-01), None
patent: 98/47516 (1998-10-01), None
patent: 00/09150 (2000-02-01), None
patent: 00/35472 (2000-06-01), None
patent: 00/43030 (2000-07-01), None
Rigopoulou et al., Blocking of IL-10 Receptor-A novel approach to stimulate virus-specific T cell reactivity in chronic hepatitis C virus (HCV) infection, Hepatology, 2000, 32(4,2), p. 304A.
Silva et al., Blocking the receptor for interleukin 10 protects mice from lethal listeriosis, Antimicrobial Agents and Chemotherapy, 2001, 45(4):1312-1314.
van Deuren et al., The Pattern of Interleukin-1b (IL-1b) and Its Modulating Agents IL-1 Receptor Antagonist and IL-1 Soluble Receptor Type II in Acute Meningococcal Infections, Blood, 1997, 90(3):1101-1108.
Brady et al., Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes, European Journal of Immunology, 2003, 33:3448-3457.
Tsai et al., Detection of Type 2—Like T-Helper Cells in Hepatitis C Virus Infection: Implications for Hepatitis C Virus Chronicity, Hepatology, 1997, 25:449-458.
Stockl et al., Human major group rhinoviruses downmodulate the accessory function of monocytes by inducing IL-10, Journal of Clinical Investigation, 1999, 104:957-965.
Li et al., Interferon-gamma (IFN-γ) regulates production of IL-10 and IL-12 in human herpesvirus-6 (HHV-6)-infected monocyte/macrophage lineage, Clin. Exp. Immunol., 1997, 109:421-425.
Asadullah, K., et al., Interleukin-10 therapy—review of a new approach, Pharmacological Reviews, 55:241-269 (2003).
Belkaid, Y., et al., The role of interleukin (IL)-10 in the persistence ofLeishmania majorin the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure, J. Exp. Med., 194:1497-1506 (2001).
Bogdan, C., et al., Machophage deactivation by interleukin 10, J. Exp. Med., 174:1549-1555 (1991).
Chang, W.L.W., et al., Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality, Journal of Virology, 78:8720-8731 (2004).
Ding, Y., et al., Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses, The Journal of Immunology, 170:1383-1391 (2003).
Fernandez, S., et al., Inhibition of IL-10 receptor function in Alveolar macrophages by toll-like receptor agonists, The Journal of Immunology, 172:2613-2620 (2004).
Groux, H., et al., A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells, Journal of Immunology, 162:1723-1729 (1999).
Havlir, D.V., et al., Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals withMycobacterium aviumcomplex disease, Journal of Clinical Microbiology, 39:298-303 (2001).
Higgins, S.C., et al., Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance toBordetella pertussisby inhibiting inflammatory pathology, The Journal of Immunology, 171:3119-3127 (2003).
Ho, A. S.-Y., et al., A receptor for interleukin 10 is related to interferon receptors, Proc. Natl. Acad. Sci. USA, 90:11267-11271 (1993).
Ho, A. S.-Y., et al., Interleukin-10 and its receptor, Therapeutic Immunology, 1:173-185 (1994).
Jones, K.D., et al., Involvement of interleukin-10(IL-10) and viral IL-6 in the spontaneous growth of kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells, Blood, 94:2871-2879 (1999).
Josephson, K., et al., Noncompetitive antibody neutralization of IL-10 revealed by protein engineering and X-ray crystallography, Structure, 10:981-987 (2002).
Kane, M.M., et al., The role of IL-10 in promoting disease progression in Leishmaniasis, The Journal of Immunology, 166:1141-1147 (2001).
Kotenko, S.V., et al., Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10), PNAS, 97:1695-1700 (2000).
Laichalk, L., et al., Interleukin-10 inhibits neutrophil phagocytic and bactericidal activity, FEMS Immunology and Medical Microbiology 15:181-187 (1996).
Liu, Y., et al., The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor, The Journal of Immunology, 158:604-613 (1997).
Lyons, A, et al., Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection, Annals of Surgery, 226:450-460 (1997).
Moore, K.W., et al., Interleukin-10 and the interleukin-10 receptor, Annu. Rev. Immunol., 19:683-765 (2001).
Muehlstedt, S.G., et al., Increased IL-10 production and HLA-DR suppression in the lungs of injured patients precede the development of nosocomial pneumonia, Shock, 17:443-450 (2002).
Murray, H., et al., Determinants of response to interleukin-10 receptor blockage immunotherapy in experimental visceral leishmaniasis, Journal of Infectious Diseases, 188:458-464 (2003).
Murray, H., Interleukin 10 receptor blockage—pentavalent antimony treatment in experimental visceral leishmaniasis, Acta Tropica, 93:295-301 (2005).
Murray, H.W., et al., Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockage as immunotherapy, Infection and Immunity, 70:6284-6293 (2002).
O'Farrell, A.-M., et al., IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways, The EMBO Journal, 17:1006-1018 (1998).
Opal, S.M., et al., The role of interleukin-10 in critical illness, Current Opinion in Infectious Diseases, 12:221-226 (2000).
Payvandi, F., et al., Exogenous and Endogenous IL-10 regulate IFN-α production by peripheral blood mononuclear cells in response to viral stimulation, Journal of Immunology, 160:5861-5868 (1998).
Redpath, S., et al., Hijacking and exploitation of IL-10 by intracellular pathogens, Trends in Microbiology, 9:86-92 (2001).
Silva, R.A., et al., Blocking the receptor for IL-10 improves antimycobacterial chemotherapy and vaccination, The Journal of Immunology, 167:1535-1541 (2001).
Spencer, J.V., et al., Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10, Journal of Virology, 76:1285-1292 (2002).
Spencer, S.D., et al., The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor, J. Exp. Med., 187:571-578 (1998).
Stylianou, E., et al., IL-10 in HIV infection: increasing serum IL-10 levels with disease Progression—Down-Regulatory Effect of potent anti-retroviral therapy. Clin. Exp. Immunol., 116:115-120 (1999).
Suzuki, T., et al., Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors, J. Exp. Med., 182:477-486 (1995).
Vicari, A.P., et al., Interleukin-10 in viral diseases and cancer: exiting the labyrinth?. Immunological Review 202:223-236 (2004).
Humphreys, et al., Cytomegalovirus Exploits IL-10-Mediated Immune Regulation in the Salivary Glands,JEM204(5): 1217-1225 (2007).
Rigopoulou, et al., Blocking of Interleukin-10 Receptor-A Novel Approach to Stimulate T-Helper Cell Type 1 Responses to Hepatitis C. Virus,Clinical Immunology117:57-64 (2005).
Ejrnaes Anne Mette
Von Herrath Matthias G.
Campell Bruce
Kinsey White Nicole
La Jolla Institute for Allergy and Immunology
Pillsbury Winthrop Shaw & Pittman LLP
LandOfFree
Methods of treating viral infection with IL-10 receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating viral infection with IL-10 receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating viral infection with IL-10 receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4061033